Are you in the global race? Where do you stand in the cut throat global competition?
Fierce competition, stringent regulations, diminishing research and development, shrinking margins, strong price pressures and patent cliffs encompass today’s drug industry. It is a well-known fact that future of the pharmaceutical/biopharmaceutical industry depends on innovation, and innovation comes from collaborations or partnerships.
Buy this report to find out an analysis of strategies adopted by Top 50 players in the market to stay ahead of their competitor.
Contract manufacturing and outsourcing in the form of pay for services or strategic collaboration has resulted in the development of a new paradigm that offers new opportunities to companies for improving their bottom lines through the conversion of fixed costs to variable costs. Contract manufacturers that perform custom synthesis and produce intermediates, active pharmaceutical ingredients and dosage forms are becoming increasingly important for the drug developers to conduct their business more efficiently. Rapid economic growth in the emerging markets is also advancing the pharmaceutical/biopharmaceutical contract manufacturing market. Cost, once considered the only reason for outsourcing, is now accomplished by quality and reliability.
To access the data contained in this document please email contactus@visiongain.com
How this report will benefit you?
The 395-page report provides clear detailed insight into the pharmaceutical contract manufacturing market. Discover the global top 50 rankings, top business strategies adopted by the key players, product mapping, services provided, recent activities of the companies, key drivers and challenges affecting the market.
Read on to discover how you can exploit the future business opportunities emerging in this sector. In this brand new 434-page report you will receive 400+ tables and 300+ figures– all unavailable elsewhere.
Market Insights
Boots Contract Manufacturing, a unit of Wallgreen Boots Alliance Inc., was the leader in the non-sterile liquid contract manufacturing market with a xx% share. Catalent Pharma Solutions had a 6.8% share, and GlaxoSmithKline (GSK) and Perrigo Company PLC also had notable shares in this market. Mylan N.V., Lyne Laboratories and Wockhardt Ltd. are other contributors in the non-sterile liquid dosage form market via contract manufacturing. Many renowned pharmaceutical companies such as Boehringer Ingelheim, AbbVie Inc., Dr. Reddy’s, Pharmaceutical International GmbH and Jubilant Lifesciences also contributed to this market, holding a 69.3% cumulative market share.
COVID-19 Impact on Pharmaceutical Contract Manufacturing Market
Due to the recent outbreak of COVID-19, the changing delivery chain scenario is likely to have a prominent effect in the short term on global contract manufacturing, including China. The demand for large-scale contract manufacturing is expected to increase significantly as pharmaceutical companies start full-scale operations following the coronavirus outbreak. After the end of the COVID-19 pandemic, several organizations will seek to increase their productivity to meet the growing demand. This means that such larger companies should appoint contract development and manufacturing organizations to deal with losses suffered during the crisis. In addition, numerous governmental bodies develop innovative plans to boost contract development and producing organizations to boost productivity for other bigger organizations.
By ordering and reading our brand-new report today you stay better informed and ready to act. Visiongain’s study is intended for anyone requiring commercial analyses for the top 50 pharmaceutical contract manufacturing market. You find data, trends and predictions.
Companies Profiled in the Report
• AbbVie Inc Company
• Aenova Group Company
• Ajinomoto Bio-Pharma Services Company
• Alcami Corporation Company
• Alkermes Biotechnology company
• Almac Group Company
• Aurobindo Pharma Ltd.
• Avid Bioservices Inc.
• Baxter Biopharma Solutions Company
• Bayer AG Company
• Biocon Limited Company
• Biomay AG Company
• Biophore India Pharmaceuticals Private Limited Company
• Bora Pharmaceuticals Company
• C.H. Boehringer Sohn AG & Ko. KG Company
• Cambrex Corporation Company
• Cardinal Health, Inc. Company
• Catalent Pharma Solutions Inc.
• Cepia Sanofi Company (Parental of Sanofi)
• Charles River Laboratories International, Inc. Company
• Consort Medical plc
• Corden Pharma International Company
• Daito Pharmaceutical Co., Ltd. Company
• Delpharm SAS Company
• Divi’s Laboratories Ltd
• DPT Laboratories, Ltd. (Mylan N.V.) Company
• Dr. Reddy’s Laboratories Company
• Evonik Degussa Company
• F. Hoffmann-La Roche Ltd
• Famar S.A. Company
• Fareva Pharmaceuticals Company
• Fujifilm Diosynth Biotechnologies (Merck & co subsidiaries)
• GlaxoSmithKline Pharmaceutical Company
• Huapont Life Sciences Co Ltd Company
• Koninklijke DSM N.V. (Royal DSM) Company
• Lonza AG Company
• Nipro Corporation
• Pfizer Company
• Recipharm AB Company
• SAFC Biosciences (Merck KGaA Subsidiaries) Company
• Samsung Biologics Company
• Siegfried Holding Company
• Strides Pharma Science Limited Company
• Teva Pharmaceuticals Company
• Therapure Biopharma, Inc. Company
• Thermo Fisher Scientific Inc.
• UPM Pharmaceuticals Company
• Vetter Pharma Company
• WuXi AppTec Company
• Zhejiang Hisun Pharmaceutical Company
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Pharma Leader Series: Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Report 2021: In-depth Analysis of Top 50 Pharma CMOs: Capabilities, Results, Competition and Sales Potentials. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1 Report Overview
1.1 Scope of Report
1.2 Why You Should Buy This Report
1.3 How This Report Delivers
1.4 Key Questions Answered by This Analytical Report Include:
1.5 Who is This Report For?
1.6 Methodology
1.6.1 Primary Research
1.6.2 Secondary Research
1.7 Market Evaluation & Forecasting Methodology
1.8 COIVD-19 Impact Recovery Pattern Analysis
1.8.1 V-Shaped Recovery
1.8.2 U-Shaped Recovery
1.8.3 W-Shaped Recovery
1.8.4 L-Shaped Recovery
1.9 Frequently Asked Questions (FAQ)
1.10 Associated Visiongain Reports
1.11 About Visiongain
2 Executive Summary
2.1 Pharmaceutical Product Manufacturing Segment is Expected to Maintain its Dominance in the Global Market
2.2 COVID-19 Impact on Pharmaceutical Contract Manufacturing Market
3 Market Dynamics
3.1 Factors Affecting Growth
3.1.1 Product and Process Innovation
3.1.2 Continuing Focus on Productivity
3.1.3 Cost Savings
3.1.4 Risk Management
3.1.5 Stringent Regulations
3.1.6 Patent Expirations
3.1.7 Decreasing Research and Development Success Rates
3.2 Market Drivers
3.2.1 Increasing Demand of Biosimilars
3.2.2 Increased Focus on Orphan and Specialty Drugs
3.2.3 Generics: A Driver or Restraint?
3.2.4 Increasing Demand for Formulation Development Services
3.2.5 Bio/Pharmaceutical Manufacturers’ Move Toward Strategic Collaboration With Drug Delivery Technology Companies
3.3 Opportunities in the Global Market
3.3.1 Lack of Manufacturing and Packaging Capabilities
3.3.2 Pharma Companies Will Continue To Look For Ways To Cut Drug Costs
3.3.3 Need for New Drug Delivery Technologies
3.3.4 Chemical APIs Will Experience Resurgence after the Shift of Focus to Biological APIs
3.4 Growth Restrain
3.4.1 Backwards Integration for Generics Manufacturers
3.4.2 The US Generic Drug User Fee Act and API Manufacturing
3.4.3 Challenges in Contract Manufacturing
3.4.4 Challenges in Assessing the Market: Supply versus Demand
3.5 SWOT Analysis
3.6 Porter’s Five Forces Analysis
3.6.1 What are Porter Five (5) Forces
3.6.2 Threat of New Entrants (Low to Moderate)
3.6.3 Rivalry Among the Existing Players (High)
3.6.4 Bargaining Power of Suppliers (Low)
3.6.5 Threats from Substitute Products (Low to Moderate)
3.6.6 Bargaining Power of Buyers (High)
4 Global Pharmaceutical Contract Manufacturing Market
4.1 Industry Structure Overview
4.1.1 Big Pharmaceutical Contract Manufacturing Companies Overview
4.1.2 Small & Mid-size Pharmaceutical Contract Manufacturing Companies Overview
4.1.3 Pharmaceutical Landscape
4.1.4 Objectives of Outsourcing
4.1.5 Contract Manufacturing Types
4.1.6 Suitable Services Provider
4.1.7 Benefits of Outsourcing
4.1.8 Drawbacks of Outsourcing
4.1.9 Outsourcing
4.1.10 Core Capabilities of Contract Manufacturing Organization
4.1.11 Services Offered by Contract Manufacturing Organizations
5 Global Pharmaceutical Contract Manufacturing Market
5.1 Overview
5.1.1 Analysis of Market Status Before COVID-19
5.1.2 Analysis of Market V-Shaped Recovery Pattern
5.1.3 Analysis of Market W-Shaped Recovery Pattern
5.1.4 Analysis of Market U-Shaped Recovery Pattern
5.1.5 Analysis of Market L-Shaped Recovery Pattern
5.2 Regional Market Overview
5.2.1 Analysis of Market Status Before COVID-19
5.2.2 Analysis of Market V-Shaped Recovery Pattern
5.2.3 Analysis of Market W-Shaped Recovery Pattern
5.2.4 Analysis of Market U-Shaped Recovery Pattern
5.2.5 Analysis of Market L-Shaped Recovery Pattern
6 Competitive Landscape
6.1 Strategy and Tactics: The Importance of Outsourcing Wisely
6.2 Market Leaders
6.3 Market Shares
6.3.1 Bulk Drugs and APIs
6.3.2 Solid Dosage Forms
6.3.3 Liquid Dosage Forms
6.3.4 Semi-Solid Dosage Forms
6.4 Contract Research
6.4.1 Market Leaders
6.4.2 Market Shares
7 Top 20 Big CMOs Dominating the Global Market
7.1 What is the Current Status of Big CMOs in the Global Market?
7.2 Cardinal Health, Inc. Company
7.2.1 Company Information
7.2.2 Company Overview
7.2.3 Company Product Offerings
7.2.4 Company Financials, 2019
7.2.5 Company Recent Developments
7.2.6 Company SWOT Analysis
7.2.7 Company Key Competitors in the Global CMO Market
7.2.8 Company Future Outlook
7.3 F. Hoffmann-La Roche Ltd
7.3.1 Company Information
7.3.2 Company Overview
7.3.3 Company Product Offerings
7.3.4 Company Manufacturing Locations
7.3.5 Company Financials, 2019
7.3.6 Company Recent Developments
7.3.7 Company SWOT Analysis
7.3.8 Company Key Competitors in the Global CMO Market
7.3.9 Company Future Outlook
7.4 Pfizer Company
7.4.1 Company Information
7.4.2 Company Overview
7.4.3 Company Product Offerings
7.4.4 Company Financials, 2019
7.4.5 Company Recent Developments
7.4.6 Company SWOT Analysis
7.4.7 Company Key Competitors in the Global CMO Market
7.4.8 Company Future Outlook
7.5 Bayer AG Company
7.5.1 Company Information
7.5.2 Company Overview
7.5.3 Company Financials, 2019
7.5.4 Company Product Offerings
7.5.5 Company Manufacturing Locations
7.5.6 Company Recent Developments
7.5.7 Company SWOT Analysis
7.5.8 Company Key Competitors in the Global CMO Market
7.5.9 Company Future Outlook
7.6 GlaxoSmithKline Pharmaceutical Company
7.6.1 Company Information
7.6.2 Company Overview
7.6.3 Company Product Offerings
7.6.4 Company Manufacturing Locations
7.6.5 Company Financials, 2019
7.6.6 Company Recent Developments
7.6.7 Company SWOT Analysis
7.6.8 Company Key Competitors in the Global CMO Market
7.6.9 Company Future Outlook
7.7 Cepia Sanofi Company (Parental of Sanofi)
7.7.1 Company Information
7.7.2 Company Overview
7.7.3 Company Product Offerings
7.7.4 Company Financials, 2019
7.7.5 Company Recent Developments
7.7.6 Company SWOT Analysis
7.7.7 Company Key Competitors in the Global CMO Market
7.7.8 Company Future Outlook
7.8 Fujifilm Diosynth Biotechnologies (Merck & co subsidiaries)
7.8.1 Company Information
7.8.2 Company Overview
7.8.3 Company Product Offerings
7.8.4 Company Financials, 2019
7.8.5 Company Recent Developments
7.8.6 Company SWOT Analysis
7.8.7 Company Key Competitors in the Global CMO Market
7.8.8 Company Future Outlook
7.9 AbbVie Inc Company
7.9.1 Company Information
7.9.2 Company Overview
7.9.3 Company Product Offerings
7.9.4 Company Manufacturing Locations
7.9.5 Company Financials, 2019
7.9.6 Company Recent Developments
7.9.7 Company SWOT Analysis
7.9.8 Company Key Competitors in the Global CMO Market
7.9.9 Company Future Outlook
7.10 Thermo Fisher Scientific Inc.
7.10.1 Company Information
7.10.2 Company Overview
7.10.3 Company Product Offerings
7.10.4 Company Financials, 2019
7.10.5 Company Recent Developments
7.10.6 Company SWOT Analysis
7.10.7 Company Key Competitors in the Global CMO Market
7.10.8 Company Future Outlook
7.11 C.H. Boehringer Sohn AG & Ko. KG Company
7.11.1 Company Information
7.11.2 Company Overview
7.11.3 Company Product Offerings
7.11.4 Company Financials, 2019
7.11.5 Company Recent Developments
7.11.6 Company SWOT Analysis
7.11.7 Company Key Competitors in the Global CMO Market
7.11.8 Company Future Outlook
7.12 SAFC Biosciences (Merck KGaA Subsidiaries) Company
7.12.1 Company Information
7.12.2 Company Overview
7.12.3 Company Product Offerings
7.12.4 Company Financials, 2019
7.12.5 Company Recent Developments
7.12.6 Company SWOT Analysis
7.12.7 Company Key Competitors in the Global CMO Market
7.12.8 Company Future Outlook
7.13 Teva Pharmaceuticals Company
7.13.1 Company Information
7.13.2 Company Overview
7.13.3 Company Product Offerings
7.13.4 Company Financials, 2019
7.13.5 Company Recent Developments
7.13.6 Company SWOT Analysis
7.13.7 Company Key Competitors in the Global CMO Market
7.13.8 Company Future Outlook
7.14 Evonik Degussa Company
7.14.1 Company Information
7.14.2 Company Overview
7.14.3 Company Product Offerings
7.14.4 Company Financials, 2019
7.14.5 Company Recent Developments
7.14.6 Company SWOT Analysis
7.14.7 Company Key Competitors in the Global CMO Market
7.14.8 Company Future Outlook
7.15 Baxter Biopharma Solutions Company
7.15.1 Company Information
7.15.2 Company Overview
7.15.3 Company Product Offerings
7.15.4 Company Manufacturing Locations
7.15.5 Company Financials, 2019
7.15.6 Company Recent Developments
7.15.7 Company SWOT Analysis
7.15.8 Company Key Competitors in the Global CMO Market
7.15.9 Company Future Outlook
7.16 Koninklijke DSM N.V. (Royal DSM) Company
7.16.1 Company Information
7.16.2 Company Overview
7.16.3 Company Product Offerings
7.16.4 Company Manufacturing Locations
7.16.5 Company Financials, 2019
7.16.6 Company Recent Developments
7.16.7 Company SWOT Analysis
7.16.8 Company Key Competitors in the Global CMO Market
7.16.9 Company Future Outlook
7.17 Lonza AG Company
7.17.1 Company Information
7.17.2 Company Overview
7.17.3 Company Product Offerings
7.17.4 Company Manufacturing Locations
7.17.5 Company Financials, 2019
7.17.6 Company Recent Developments
7.17.7 Company SWOT Analysis
7.17.8 Company Key Competitors in the Global CMO Market
7.17.9 Company Future Outlook
7.18 Nipro Corporation
7.18.1 Company Information
7.18.2 Company Overview
7.18.3 Company Product Offerings
7.18.4 Company Financials, 2019
7.18.5 Company Recent Developments
7.18.6 Company SWOT Analysis
7.18.7 Company Key Competitors in the Global CMO Market
7.18.8 Company Future Outlook
7.19 Aurobindo Pharma Ltd.
7.19.1 Company Information
7.19.2 Company Overview
7.19.3 Company Product Offerings
7.19.4 Company Manufacturing Locations
7.19.5 Company Financials, 2019
7.19.6 Company Recent Developments
7.19.7 Company SWOT Analysis
7.19.8 Company Key Competitors in the Global CMO Market
7.19.9 Company Future Outlook
7.20 Charles River Laboratories International, Inc. Company
7.20.1 Company Information
7.20.2 Company Overview
7.20.3 Company Product Offerings
7.20.4 Company Financials, 2019
7.20.5 Company Recent Developments
7.20.6 Company SWOT Analysis
7.20.7 Company Key Competitors in the Global CMO Market
7.20.8 Company Future Outlook
7.21 Dr. Reddy's Laboratories Company
7.21.1 Company Information
7.21.2 Company Overview
7.21.3 Company Product Offerings
7.21.4 Company Manufacturing Locations
7.21.5 Company Financials, 2019
7.21.6 Company Recent Developments
7.21.7 Company SWOT Analysis
7.21.8 Company Key Competitors in the Global CMO Market
7.21.9 Company Future Outlook
8 Top 20 Mid-Range CMOs with Strong Foothold in the Global Pharma Market
8.1 How are the Mid-Range CMOs Performing in the Global Market?
8.2 Fareva Pharmaceuticals Company
8.2.1 Company Information
8.2.2 Company Overview
8.2.3 Company Product Offerings
8.2.4 Company Financials, 2019
8.2.5 Company Recent Developments
8.2.6 Company SWOT Analysis
8.2.7 Company Key Competitors in the Global CMO Market
8.2.8 Company Future Outlook
8.3 WuXi AppTec Company
8.3.1 Company Information
8.3.2 Company Overview
8.3.3 Company Product Offerings
8.3.4 Company Manufacturing Locations
8.3.5 Company Financials, 2019
8.3.6 Company Recent Developments
8.3.7 Company SWOT Analysis
8.3.8 Company Key Competitors in the Global CMO Market
8.3.9 Company Future Outlook
8.4 Zhejiang Hisun Pharmaceutical Company
8.4.1 Company Information
8.4.2 Company Overview
8.4.3 Company Product Offerings
8.4.4 Company Manufacturing Locations
8.4.5 Company Financials, 2019
8.4.6 Company Recent Developments
8.4.7 Company SWOT Analysis
8.4.8 Company Key Competitors in the Global CMO Market
8.4.9 Company Future Outlook
8.5 Huapont Life Sciences Co Ltd Company
8.5.1 Company Information
8.5.2 Company Overview
8.5.3 Company Product Offerings
8.5.4 Company Financials, 2019
8.5.5 Company Recent Developments
8.5.6 Company SWOT Analysis
8.5.7 Company Key Competitors in the Global CMO Market
8.5.8 Company Future Outlook
8.6 Alkermes Biotechnology company
8.6.1 Company Information
8.6.2 Company Overview
8.6.3 Company Product Offerings
8.6.4 Company Manufacturing Locations
8.6.5 Company Financials, 2019
8.6.6 Company Recent Developments
8.6.7 Company SWOT Analysis
8.6.8 Company Key Competitors in the Global CMO Market
8.6.9 Company Future Outlook
8.7 Siegfried Holding Company
8.7.1 Company Information
8.7.2 Company Overview
8.7.3 Company Product Offerings
8.7.4 Company Financials, 2019
8.7.5 Company Recent Developments
8.7.6 Company SWOT Analysis
8.7.7 Company Key Competitors in the Global CMO Market
8.7.8 Company Future Outlook
8.8 Recipharm AB Company
8.8.1 Company Information
8.8.2 Company Overview
8.8.3 Company Product Offerings
8.8.4 Company Financials, 2019
8.8.5 Company Recent Developments
8.8.6 Company SWOT Analysis
8.8.7 Company Key Competitors in the Global CMO Market
8.8.8 Company Future Outlook
8.9 Biocon Limited Company
8.9.1 Company Information
8.9.2 Company Overview
8.9.3 Company Product Offerings
8.9.4 Company Financials, 2019
8.9.5 Company Recent Developments
8.9.6 Company SWOT Analysis
8.9.7 Company Key Competitors in the Global CMO Market
8.9.8 Company Future Outlook
8.10 Almac Group Company
8.10.1 Company Information
8.10.2 Company Overview
8.10.3 Company Product Offerings
8.10.4 Company Financials, 2019
8.10.5 Company Recent Developments
8.10.6 Company SWOT Analysis
8.10.7 Company Key Competitors in the Global CMO Market
8.10.8 Company Future Outlook
8.11 Vetter Pharma Company
8.11.1 Company Information
8.11.2 Company Overview
8.11.3 Company Product Offerings
8.11.4 Company Financials, 2019
8.11.5 Company Recent Developments
8.11.6 Company SWOT Analysis
8.11.7 Company Key Competitors in the Global CMO Market
8.11.8 Company Future Outlook
8.12 Divi's Laboratories Ltd
8.12.1 Company Information
8.12.2 Company Overview
8.12.3 Company Product Offerings
8.12.4 Company Financials, 2019
8.12.5 Company Recent Developments
8.12.6 Company SWOT Analysis
8.12.7 Company Key Competitors in the Global CMO Market
8.12.8 Company Future Outlook
8.13 Cambrex Corporation Company
8.13.1 Company Information
8.13.2 Company Overview
8.13.3 Company Product Offerings
8.13.4 Company Financials, 2019
8.13.5 Company Recent Developments
8.13.6 Company SWOT Analysis
8.13.7 Company Key Competitors in the Global CMO Market
8.13.8 Company Future Outlook
8.14 Samsung Biologics Company
8.14.1 Company Information
8.14.2 Company Overview
8.14.3 Company Product Offerings
8.14.4 Company Financials, 2019
8.14.5 Company Recent Developments
8.14.6 Company SWOT Analysis
8.14.7 Company Key Competitors in the Global CMO Market
8.14.8 Company Future Outlook
8.15 DPT Laboratories, Ltd. (Mylan N.V.) Company
8.15.1 Company Information
8.15.2 Company Overview
8.15.3 Company Product Offerings
8.15.4 Company Financials, 2019
8.15.5 Company Recent Developments
8.15.6 Company SWOT Analysis
8.15.7 Company Key Competitors in the Global CMO Market
8.15.8 Company Future Outlook
8.16 Aenova Group Company
8.16.1 Company Information
8.16.2 Company Overview
8.16.3 Company Product Offerings
8.16.4 Company Financials, 2019
8.16.5 Company Recent Developments
8.16.6 Company SWOT Analysis
8.16.7 Company Key Competitors in the Global CMO Market
8.16.8 Company Future Outlook
8.17 Daito Pharmaceutical Co., Ltd. Company
8.17.1 Company Information
8.17.2 Company Overview
8.17.3 Company Product Offerings
8.17.4 Company Financials, 2019
8.17.5 Company Recent Developments
8.17.6 Company SWOT Analysis
8.17.7 Company Key Competitors in the Global CMO Market
8.17.8 Company Future Outlook
8.18 Ajinomoto Bio-Pharma Services Company
8.18.1 Company Information
8.18.2 Company Overview
8.18.3 Company Product Offerings
8.18.4 Company Financials, 2019
8.18.5 Company Recent Developments
8.18.6 Company SWOT Analysis
8.18.7 Company Key Competitors in the Global CMO Market
8.18.8 Company Future Outlook
8.19 Strides Pharma Science Limited Company
8.19.1 Company Information
8.19.2 Company Overview
8.19.3 Company Product Offerings
8.19.4 Company Financials, 2019
8.19.5 Company Recent Developments
8.19.6 Company SWOT Analysis
8.19.7 Company Key Competitors in the Global CMO Market
8.19.8 Company Future Outlook
8.20 Consort Medical plc
8.20.1 Company Information
8.20.2 Company Overview
8.20.3 Company Product Offerings
8.20.4 Company Financials, 2019
8.20.5 Company Recent Developments
8.20.6 Company SWOT Analysis
8.20.7 Company Key Competitors in the Global CMO Market
8.20.8 Company Future Outlook
8.21 Alcami Corporation Company
8.21.1 Company Information
8.21.2 Company Overview
8.21.3 Company Product Offerings
8.21.4 Company Financials, 2019
8.21.5 Company Recent Developments
8.21.6 Company SWOT Analysis
8.21.7 Company Key Competitors in the Global CMO Market
8.21.8 Company Future Outlook
9 Top 10 CMOs to Watch in the Global Pharma Market
9.1 The Long Biopharmaceutical Pipeline Will Also Act As A Driver For Growth Of Small CMOs
9.2 Catalent Pharma Solutions Inc.
9.2.1 Company Information
9.2.2 Company Overview
9.2.3 Company Product Offerings
9.2.4 Company Manufacturing Locations
9.2.5 Company Financials, 2019
9.2.6 Company Recent Developments
9.2.7 Company SWOT Analysis
9.2.8 Company Key Competitors in the Global CMO Market
9.2.9 Company Future Outlook
9.3 Avid Bioservices Inc.
9.3.1 Company Information
9.3.2 Company Overview
9.3.3 Company Product Offerings
9.3.4 Company Manufacturing Locations
9.3.5 Company Financials, 2019
9.3.6 Company Recent Developments
9.3.7 Company SWOT Analysis
9.3.8 Company Key Competitors in the Global CMO Market
9.3.9 Company Future Outlook
9.4 Famar S.A. Company
9.4.1 Company Information
9.4.2 Company Overview
9.4.3 Company Product Offerings
9.4.4 Company Financials, 2019
9.4.5 Company Recent Developments
9.4.6 Company SWOT Analysis
9.4.7 Company Key Competitors in the Global CMO Market
9.4.8 Company Future Outlook
9.5 Bora Pharmaceuticals Company
9.5.1 Company Snapshot
9.5.2 Company Overview
9.5.3 Company Product Benchmarking
9.5.4 Company Financial Profile
9.5.5 Company Recent Developments
9.5.6 Company SWOT Analysis
9.5.7 Company Key Competitors in the Global Ophthalmic Market
9.5.8 Company Future Outlook
9.6 Therapure Biopharma, Inc. Company
9.6.1 Company Information
9.6.2 Company Overview
9.6.3 Company Product Offerings
9.6.4 Company Financials, 2019
9.6.5 Company Recent Developments
9.6.6 Company SWOT Analysis
9.6.7 Company Key Competitors in the Global CMO Market
9.6.8 Company Future Outlook
9.7 UPM Pharmaceuticals Company
9.7.1 Company Information
9.7.2 Company Overview
9.7.3 Company Product Offerings
9.7.4 Company Financials, 2019
9.7.5 Company Recent Developments
9.7.6 Company SWOT Analysis
9.7.7 Company Key Competitors in the Global CMO Market
9.7.8 Company Future Outlook
9.8 Delpharm SAS Company
9.8.1 Company Information
9.8.2 Company Overview
9.8.3 Company Product Offerings
9.8.4 Company Financials, 2019
9.8.5 Company Recent Developments
9.8.6 Company SWOT Analysis
9.8.7 Company Key Competitors in the Global CMO Market
9.8.8 Company Future Outlook
9.9 Corden Pharma International Company
9.9.1 Company Information
9.9.2 Company Overview
9.9.3 Company Product Offerings
9.9.4 Company Financials, 2019
9.9.5 Company Recent Developments
9.9.6 Company SWOT Analysis
9.9.7 Company Key Competitors in the Global CMO Market
9.9.8 Company Future Outlook
9.10 Biomay AG Company
9.10.1 Company Information
9.10.2 Company Overview
9.10.3 Company Product Offerings
9.10.4 Company Financials, 2019
9.10.5 Company Recent Developments
9.10.6 Company SWOT Analysis
9.10.7 Company Key Competitors in the Global CMO Market
9.10.8 Company Future Outlook
9.11 Biophore India Pharmaceuticals Private Limited Company
9.11.1 Company Information
9.11.2 Company Overview
9.11.3 Company Product Offerings
9.11.4 Company Financials, 2019
9.11.5 Company Recent Developments
9.11.6 Company SWOT Analysis
9.11.7 Company Key Competitors in the Global CMO Market
10 Conclusion and Recommendations
10.1 Will Product Reformulation Drive Growth to 2031?
10.2 Demand for Biopharma Manufacturing Will Drive Growth 2021-2031
10.3 Demand Will Be Highest Among Developed-Market Clients
10.4 How Will Biotech Funding Impact the Pharma Contract Manufacturing Industry to 2031?
11 List of Other 50 Pharmaceutical Contract Manufacturing Companies
12 Glossary
List of Tables
Table 2.1 Global Pharmaceutical Contract Manufacturing Market Summary Table
Table 5.1 Global Pharmaceutical Contract Manufacturing Market by Value Forecast 2021-2031 (US$ billion, AGR %, CAGR %)
Table 5.2 Global Pharmaceutical Contract Manufacturing Market by Value Forecast 2021-2031 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 5.3 Global Pharmaceutical Contract Manufacturing Market by Value Forecast 2021-2031 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 5.4 Global Pharmaceutical Contract Manufacturing Market by Value Forecast 2021-2031 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 5.5 Global Pharmaceutical Contract Manufacturing Market by Value Forecast 2021-2031 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 5.6 Global Pharmaceutical Contract Manufacturing Market by Region Forecast 2021-2031 (US$ billion, AGR %, CAGR %)
Table 5.7 Global Pharmaceutical Contract Manufacturing Market by Region Forecast 2021-2031 (US$ billion, AGR %, CAGR %) (V-Shaped Recovery)
Table 5.8 Global Pharmaceutical Contract Manufacturing Market by Region Forecast 2021-2031 (US$ billion, AGR %, CAGR %) (W-Shaped Recovery)
Table 5.9 Global Pharmaceutical Contract Manufacturing Market by Region Forecast 2021-2031 (US$ billion, AGR %, CAGR %) (U-Shaped Recovery)
Table 5.10 Global Pharmaceutical Contract Manufacturing Market by Region Forecast 2021-2031 (US$ billion, AGR %, CAGR %) (L-Shaped Recovery)
Table 6.1 Services Provided by Leading Pharmaceutical Contract Manufacturing Companies, 2019
Table 6.2 Global Market Share of Contract Manufacturing Companies Providing Bulk Drugs and APIs, 2019 (%)
Table 6.3 Global Market Share of Contract Manufacturing Companies Providing Solid Dosage Forms, 2019, (%)
Table 6.4 Global Market Share of Contract Manufacturing Companies Providing Nonsterile Liquid Dosage Forms, 2019 (%)
Table 6.5 Global Market Share of Contract Manufacturing Companies Providing Sterile Liquid Dosage Forms, 2019
Table 6.6 Global Market Share of Contract Manufacturing Companies Providing Semi-Solid Dosage Forms, 2019 (%)
Table 6.7 Services Provided by Leading Research Firms, 2019
Table 6.8 Global Market Share of Contract Research Companies, 2019
Table 6.9 Contracting Companies Offering Drug-Delivery Technologies and Systems, 2019
Table 7.1 Johnson & Johnson: Company Information
Table 7.2 Johnson & Johnson: Company Product and Service Offerings
Table 7.3 Johnson & Johnson: Company Financial Strengths Analysis 2019 (US$Mn)
Table 7.4 Johnson & Johnson: Company Growth Share Analysis 2019 (US$Mn)
Table 7.5 Johnson & Johnson: Company Recent Developments till Dec,2020
Table 7.6 Johnson & Johnson: SWOT Analysis
Table 7.7 F. Hoffmann-La Roche Ltd: Company Information
Table 7.8 F. Hoffmann-La Roche Ltd: Company Product and Service Offerings
Table 7.9 F. Hoffmann-La Roche Ltd: Manufacturing Locations
Table 7.10 F. Hoffmann-La Roche Ltd: Company Financial Strengths Analysis 2019 (US$Mn)
Table 7.11 F. Hoffmann-La Roche Ltd: Company Growth Share Analysis 2019 (US$Mn)
Table 7.12 F. Hoffmann-La Roche Ltd: Company Recent Developments till Dec,2020
Table 7.13 F. Hoffmann-La Roche Ltd: SWOT Analysis
Table 7.14 Pfizer Pharmaceutical: Company Information
Table 7.15 Pfizer Pharmaceutical: Company Product and Service Offerings
Table 7.16 Pfizer Pharmaceutical: Company Financial Strengths Analysis 2019 (US$Mn)
Table 7.17 Pfizer Pharmaceutical: Company Growth Share Analysis 2019 (US$Mn)
Table 7.18 Pfizer Pharmaceutical: Company Recent Developments till Dec,2020
Table 7.19 Pfizer Pharmaceutical: SWOT Analysis
Table 7.20 Bayer Pharmaceutics: Company Information
Table 7.21 Bayer Pharmaceutics: Company Financial Strengths Analysis 2019 (US$Mn)
Table 7.22 Bayer Pharmaceutics: Company Growth Share Analysis 2019 (US$Mn)
Table 7.23 Bayer Pharmaceutics: Company Product and Service Offerings
Table 7.24 Bayer Pharmaceutics: Manufacturing Locations
Table 7.25 Bayer Pharmaceutics: Company Recent Developments till Dec,2020
Table 7.26 Bayer Pharmaceutics: SWOT Analysis
Table 7.27 Novartis Pharmaceutical: Company Information
Table 7.28 Novartis Pharmaceutical: Company Product and Service Offerings
Table 7.29 Novartis Pharmaceutical: Manufacturing Locations
Table 7.30 Novartis Pharmaceutical: Company Financial Strengths Analysis 2019 (US$Mn)
Table 7.31 Novartis Pharmaceutical: Company Growth Share Analysis 2019 (US$Mn)
Table 7.32 Novartis Pharmaceutical: Company Recent Developments till Dec,2020
Table 7.33 Novartis Pharmaceutical: SWOT Analysis
Table 7.34 Merck & Co. Inc: Company Information
Table 7.35 Merck & Co. Inc: Company Product and Service Offerings
Table 7.36 Merck & Co. Inc: Company Financial Strengths Analysis 2019 (US$Mn)
Table 7.37 Merck & Co. Inc: Company Growth Share Analysis 2019 (US$Mn)
Table 7.38 Merck & Co. Inc: Company Recent Developments till Dec,2020
Table 7.39 Merck & Co. Inc: SWOT Analysis
Table 7.40 GlaxoSmithKline Pharmaceutical: Company Information
Table 7.41 GlaxoSmithKline Pharmaceutical: Company Product and Service Offerings
Table 7.42 GlaxoSmithKline Pharmaceutical: Manufacturing Locations
Table 7.43 GlaxoSmithKline Pharmaceutical: Company Financial Strengths Analysis 2019 (US$Mn)
Table 7.44 GlaxoSmithKline Pharmaceutical: Company Growth Share Analysis 2019 (US$Mn)
Table 7.45 GlaxoSmithKline Pharmaceutical: Company Recent Developments till Dec,2020
Table 7.46 GlaxoSmithKline Pharmaceutical: Company Name: SWOT Analysis
Table 7.47 Sanofi Pharmaceutical: Company Information
Table 7.48 Sanofi Pharmaceutical: Company Product and Service Offerings
Table 7.49 Sanofi Pharmaceutical: Company Financial Strengths Analysis 2019 (US$Mn)
Table 7.50 Sanofi Pharmaceutical: Company Growth Share Analysis 2019 (US$Mn)
Table 7.51 Sanofi Pharmaceutical: Company Recent Developments till Dec,2020
Table 7.52 Sanofi Pharmaceutical: SWOT Analysis
Table 7.53 AbbVie Inc.: Company Information
Table 7.54 AbbVie Inc: Company Product and Service Offerings
Table 7.55 AbbVie Inc: Manufacturing Locations
Table 7.56 AbbVie Inc Company Financial Strengths Analysis 2019 (US$Mn)
Table 7.57 AbbVie Inc Company Growth Share Analysis 2019 (US$Mn)
Table 7.58 AbbVie Inc: Company Recent Developments till Dec,2020
Table 7.59 AbbVie Inc: SWOT Analysis
Table 7.60 Abbott Laboratories: Company Information
Table 7.61 Abbott Laboratories: Company Product and Service Offerings
Table 7.62 Abbott Laboratories: Company Financial Strengths Analysis 2019 (US$Mn)
Table 7.63 Abbott Laboratories: Company Growth Share Analysis 2019 (US$Mn)
Table 7.64 Abbott Laboratories: Company Recent Developments till Dec,2020
Table 7.65 Abbott Laboratories: SWOT Analysis
Table 7.66 Thermo Fisher Scientific Inc: Company Information
Table 7.67 Thermo Fisher Scientific Inc: Company Product and Service Offerings
Table 7.68 Thermo Fisher Scientific Inc: Company Financial Strengths Analysis 2019 (US$Mn)
Table 7.69 Thermo Fisher Scientific Inc: Company Growth Share Analysis 2019 (US$Mn)
Table 7.70 Thermo Fisher Scientific Inc: Company Recent Developments till Dec,2020
Table 7.71 Thermo Fisher Scientific Inc: SWOT Analysis
Table 7.72 AstraZeneca Pharmaceutical: Company Information
Table 7.73 AstraZeneca Pharmaceutical: Company Product and Service Offerings
Table 7.74 AstraZeneca Pharmaceutical: Company Financial Strengths Analysis 2019 (US$Mn)
Table 7.75 AstraZeneca Pharmaceutical: Company Growth Share Analysis 2019 (US$Mn)
Table 7.76 AstraZeneca Pharmaceutical: Company Recent Developments till Dec,2020
Table 7.77 AstraZeneca Pharmaceutical: SWOT Analysis
Table 7.78 Eli Lily and Company: Company Information
Table 7.79 Eli Lily and Company: Company Product and Service Offerings
Table 7.80 Eli Lily and Company: Company Financial Strengths Analysis 2019 (US$Mn)
Table 7.81 Eli Lily and Company: Company Growth Share Analysis 2019 (US$Mn)
Table 7.82 Eli Lily and Company: Company Recent Developments till Dec,2020
Table 7.83 Eli Lily and Company: SWOT Analysis
Table 7.84 Gilead Science Inc: Company Information
Table 7.85 Gilead Science Inc: Company Product and Service Offerings
Table 7.86 Gilead Science Inc: Manufacturing Locations
Table 7.87 Gilead Science Inc: Company Financial Strengths Analysis 2019 (US$Mn)
Table 7.88 Gilead Science Inc: Company Growth Share Analysis 2019 (US$Mn)
Table 7.89 Gilead Science Inc: Company Recent Developments till Dec,2020
Table 7.90 Gilead Science Inc: SWOT Analysis
Table 7.91 DuPont Chemical: Company Information
Table 7.92 DuPont Chemical: Company Product and Service Offerings
Table 7.93 DuPont Chemical: Company Financial Strengths Analysis 2019 (US$Mn)
Table 7.94 DuPont Chemical: Company Growth Share Analysis 2019 (US$Mn)
Table 7.95 DuPont Chemical: Company Recent Developments till Dec,2020
Table 7.96 DuPont Chemical: SWOT Analysis
Table 7.97 Novo Nordisk Pharmaceutical: Company Information
Table 7.98 Novo Nordisk Pharmaceutical: Company Product and Service Offerings
Table 7.99 Novo Nordisk Pharmaceutical: Company Financial Strengths Analysis 2019 (US$Mn)
Table 7.100 Company Growth Share Analysis 2019 (US$Mn)
Table 7.101 Novo Nordisk Pharmaceutical: Company Recent Developments till Dec,2020
Table 7.102 Novo Nordisk Pharmaceutical: SWOT Analysis
Table 7.103 Merck KGaA: Company Information
Table 7.104 Merck KGaA: Company Product and Service Offerings
Table 7.105 Merck KGaA: Company Financial Strengths Analysis 2019 (US$Mn)
Table 7.106 Merck KGaA: Company Growth Share Analysis 2019 (US$Mn)
Table 7.107 Merck KGaA: Company Recent Developments till Dec,2020
Table 7.108 Merck KGaA: SWOT Analysis
Table 7.109 Siemens Healthineers Healthcare: Company Information
Table 7.110 Siemens Healthineers Healthcare: Company Product and Service Offerings
Table 7.111 Siemens Healthineers Healthcare: Company Financial Strengths Analysis 2019 (US$Mn)
Table 7.112 Siemens Healthineers Healthcare: Company Growth Share Analysis 2019 (US$Mn)
Table 7.113 Siemens Healthineers Healthcare: Company Recent Developments till Dec,2020
Table 7.114 Siemens Healthineers Healthcare: SWOT Analysis
Table 7.115 Becton Dickinson Medical device: Company Information
Table 7.116 Becton Dickinson Medical device: Company Product and Service Offerings
Table 7.117 Becton Dickinson Medical device: Company Financial Strengths Analysis 2019 (US$Mn)
Table 7.118 Becton Dickinson Medical device: Company Growth Share Analysis 2019 (US$Mn)
Table 7.119 Becton Dickinson Medical device: Company Recent Developments till Dec,2020
Table 7.120 Becton Dickinson Medical device: SWOT Analysis
Table 7.121 Teva Pharmaceutical: Company Information
Table 7.122 Teva Pharmaceutical: Company Product and Service Offerings
Table 7.123 Teva Pharmaceutical: Company Financial Strengths Analysis 2019 (US$Mn)
Table 7.124 Teva Pharmaceutical: Company Growth Share Analysis 2019 (US$Mn)
Table 7.125 Teva Pharmaceutical: Company Recent Developments till Dec,2020
Table 7.126 Teva Pharmaceutical: SWOT Analysis
Table 7.127 Evonik Industries: Company Information
Table 7.128 Evonik Industries: Company Product and Service Offerings
Table 7.129 Evonik Industries: Company Financial Strengths Analysis 2019 (US$Mn)
Table 7.130 Evonik Industries: Company Growth Share Analysis 2019 (US$Mn)
Table 7.131 Evonik Industries: Company Recent Developments till Dec,2020
Table 7.132 Evonik Industries: SWOT Analysis
Table 7.133 Stryker Corporation: Company Information
Table 7.134 Stryker Corporation: Company Product and Service Offerings
Table 7.135 Stryker Corporation: Company Financial Strengths Analysis 2019 (US$Mn)
Table 7.136 Stryker Corporation: Company Growth Share Analysis 2019 (US$Mn)
Table 7.137 Stryker Corporation: Company Recent Developments till Dec,2020
Table 7.138 Stryker Corporation: SWOT Analysis
Table 7.139 Baxter Biopharma Solutions: Company Information
Table 7.140 Baxter Biopharma Solutions: Company Product and Service Offerings
Table 7.141 Baxter Biopharma Solutions: Manufacturing Locations
Table 7.142 Baxter Biopharma Solutions: Company Financial Strengths Analysis 2019 (US$Mn)
Table 7.143 Baxter Biopharma Solutions: Company Growth Share Analysis 2019 (US$Mn)
Table 7.144 Baxter Biopharma Solutions: Company Recent Developments till Dec,2020
Table 7.145 Baxter Biopharma Solutions: SWOT Analysis
Table 7.146 Boston Scientific Manufacturing: Company Information
Table 7.147 Boston Scientific Manufacturing: Company Product and Service Offerings
Table 7.148 Boston Scientific Manufacturing: Company Financial Strengths Analysis 2019 (US$Mn)
Table 7.149 Boston Scientific Manufacturing: Company Growth Share Analysis 2019 (US$Mn)
Table 7.150 Boston Scientific Manufacturing: Company Recent Developments till Dec,2020
Table 7.151 Boston Scientific Manufacturing: SWOT Analysis
Table 7.152 Koninklijke DSM N.V.: Company Information
Table 7.153 Koninklijke DSM N.V.: Company Product and Service Offerings
Table 7.154 Koninklijke DSM N.V.: Manufacturing Locations
Table 7.155 Koninklijke DSM N.V: Company Financial Strengths Analysis 2019 (US$Mn)
Table 7.156 Koninklijke DSM N.V: Company Growth Share Analysis 2019 (US$Mn)
Table 7.157 Koninklijke DSM N.V.: Company Recent Developments till Dec,2020
Table 7.158 Koninklijke DSM N.V.: SWOT Analysis
Table 7.159 CSL Limited Biotechnology: Company Information
Table 7.160 CSL Limited Biotechnology: Company Product and Service Offerings
Table 7.161 CSL Limited Biotechnology: Company Financial Strengths Analysis 2019 (US$Mn)
Table 7.162 CSL Limited Biotechnology: Company Growth Share Analysis 2019 (US$Mn)
Table 7.163 CSL Limited Biotechnology: Company Recent Developments till Dec,2020
Table 7.164 CSL Limited Biotechnology: SWOT Analysis
Table 7.165 Lonza Group AG: Company Information
Table 7.166 Lonza Group AG: Company Product and Service Offerings
Table 7.167 Lonza Group AG: Manufacturing Locations
Table 7.168 Lonza Group AG: Company Financial Strengths Analysis 2019 (US$Mn)
Table 7.169 Lonza Group AG: Company Growth Share Analysis 2019 (US$Mn)
Table 7.170 Lonza Group AG: Company Recent Developments till Dec,2020
Table 7.171 Lonza Group AG: SWOT Analysis
Table 7.172 McKesson Corporation Medical: Company Information
Table 7.173 McKesson Corporation Medical: Company Product and Service Offerings
Table 7.174 McKesson Corporation Medical: Company Financial Strengths Analysis 2019 (US$Mn)
Table 7.175 McKesson Corporation Medical: Company Growth Share Analysis 2019 (US$Mn)
Table 7.176 Mckesson Corporation Medical: Company Recent Developments till Dec,2020
Table 7.177 Mckesson Corporation Medical: SWOT Analysis
Table 7.178 Edwards Lifesciences: Company Information
Table 7.179 Edwards Lifesciences: Company Recent Developments till Dec,2020
Table 7.180 Edwards Lifesciences: Company Financial Strengths Analysis 2019 (US$Mn)
Table 7.181 Edwards Lifesciences: Company Growth Share Analysis 2019 (US$Mn)
Table 7.182 Edwards Lifesciences: Company Recent Developments till Dec,2020
Table 7.183 Edwards Lifesciences: SWOT Analysis
Table 7.184 Nipro Corporation: Company Information
Table 7.185 Nipro Corporation: Company Product and Service Offerings
Table 7.186 Nipro Corporation: Company Financial Strengths Analysis 2019 (US$Mn)
Table 7.187 Nipro Corporation: Company Growth Share Analysis 2019 (US$Mn)
Table 7.188 Nipro Corporation: Company Recent Developments till Dec,2020
Table 7.189 Nipro Corporation: SWOT Analysis
Table 7.190 PPD Inc: Company Information
Table 7.191 PPD Inc: Company Product and Service Offerings
Table 7.192 PPD Inc: Manufacturing Locations
Table 7.193 PPD Inc: Company Financial Strengths Analysis 2019 (US$Mn)
Table 7.194 PPD Inc: Company Growth Share Analysis 2019 (US$Mn)
Table 7.195 PPD Inc: Company Recent Developments till Dec,2020
Table 7.196 PPD Inc: SWOT Analysis
Table 7.197 Grifols Pharmaceutical: Company Information
Table 7.198 Grifols Pharmaceutical: Company Product and Service Offerings
Table 7.199 Grifols Pharmaceutical: Company Financial Strengths Analysis 2019 (US$Mn)
Table 7.200 Grifols Pharmaceutical: Company Growth Share Analysis 2019 (US$Mn)
Table 7.201 Grifols Pharmaceutical: Company Recent Developments till Dec,2020
Table 7.202 Grifols Pharmaceutical: SWOT Analysis
Table 7.203 Biomerieux Biotechnology: Company Information
Table 7.204 Biomerieux Biotechnology Company: Company Product and Service Offerings
Table 7.205 Biomerieux Biotechnology Company: Company Financial Strengths Analysis 2019 (US$Mn)
Table 7.206 Biomerieux Biotechnology Company: Company Growth Share Analysis 2019 (US$Mn)
Table 7.207 Biomerieux Biotechnology Company: Company Recent Developments till Dec,2020
Table 7.208 Biomerieux Biotechnology Company: SWOT Analysis
Table 7.209 Aurobindo Pharma Limited: Company Information
Table 7.210 Aurobindo Pharma Limited: Company Product and Service Offerings
Table 7.211 Aurobindo Pharma Limited: Manufacturing Locations
Table 7.212 Aurobindo Pharma Limited: Company Financial Strengths Analysis 2019 (US$Mn)
Table 7.213 Aurobindo Pharma Limited: Company Growth Share Analysis 2019 (US$Mn)
Table 7.214 Aurobindo Pharma Limited: Company Recent Developments till Dec,2020
Table 7.215 Aurobindo Pharma Limited: SWOT Analysis
Table 7.216 Dr. Reddy's Laboratories: Company Information
Table 7.217 Dr. Reddy's Laboratories: Company Product and Service Offerings
Table 7.218 Dr. Reddy's Laboratories: Manufacturing Locations
Table 7.219 Dr. Reddy's Laboratories: Company Financial Strengths Analysis 2019 (US$Mn)
Table 7.220 Dr. Reddy's Laboratories: Company Growth Share Analysis 2019 (US$Mn)
Table 7.221 Dr. Reddy's Laboratories: Company Recent Developments till Dec,2020
Table 7.222 Dr. Reddy's Laboratories: SWOT Analysis
Table 7.223 Wuxi AppTec: Company Information
Table 7.224 Wuxi AppTec: Company Product and Service Offerings
Table 7.225 Wuxi AppTec: Manufacturing Locations
Table 7.226 Wuxi AppTec: Company Financial Strengths Analysis 2019 (US$Mn)
Table 7.227 Wuxi AppTec: Company Growth Share Analysis 2019 (US$Mn)
Table 7.228 Wuxi AppTec: Company Recent Developments till Dec,2020
Table 7.229 Wuxi AppTec: SWOT Analysis
Table 7.230 Huapont Life Sciences Co Ltd: Company Information
Table 7.231 Huapont Life Sciences Co Ltd: Company Product and Service Offerings
Table 7.232 Huapont Life Sciences Co Ltd: Company Financial Strengths Analysis 2019 (US$Mn)
Table 7.233 Huapont Life Sciences Co Ltd: Company Growth Share Analysis 2019 (US$Mn)
Table 7.234 Huapont Life Sciences Co Ltd: SWOT Analysis
Table 7.235 Zhejiang Hisun Pharmaceutical: Company Information
Table 7.236 Zhejiang Hisun Pharmaceutical: Company Product and Service Offerings
Table 7.237 Zhejiang Hisun Pharmaceutical: Manufacturing Locations
Table 7.238 Zhejiang Hisun Pharmaceutical: Company Financial Strengths Analysis 2019 (US$Mn)
Table 7.239 Zhejiang Hisun Pharmaceutical: Company Growth Share Analysis 2019 (US$Mn)
Table 7.240 Zhejiang Hisun Pharmaceutical: Company Recent Developments till Dec,2020
Table 7.241 Zhejiang Hisun Pharmaceutical: SWOT Analysis
Table 7.242 Alkermes Biotechnology: Company Information
Table 7.243 Alkermes Biotechnology: Manufacturing Locations
Table 7.244 Alkermes Biotechnology: Company Financial Strengths Analysis 2019 (US$Mn)
Table 7.245 Alkermes Biotechnology: Company Growth Share Analysis 2019 (US$Mn)
Table 7.246 Alkermes Biotechnology: Company Recent Developments till Dec,2020
Table 7.247 Alkermes Biotechnology: SWOT Analysis
Table 7.248 Emergent BioSolutions: Company Information
Table 7.249 Emergent BioSolutions: Company Product and Service Offerings
Table 7.250 Emergent BioSolutions: Company Financial Strengths Analysis 2019 (US$Mn)
Table 7.251 Emergent BioSolutions: Company Growth Share Analysis 2019 (US$Mn)
Table 7.252 Emergent BioSolutions: Company Recent Developments till Dec,2020
Table 7.253 Emergent BioSolutions: SWOT Analysis
Table 7.254 Divi’s Laboratories: Company Information
Table 7.255 Divi’s Laboratories: Company Product and Service Offerings
Table 7.256 Divi’s Laboratories: Company Financial Strengths Analysis 2019 (US$Mn)
Table 7.257 Divi’s Laboratories: Company Growth Share Analysis 2019 (US$Mn)
Table 7.258 Divi’s Laboratories: SWOT Analysis
Table 7.259 Bavarian Nordic: Company Information
Table 7.260 Bavarian Nordic: Company Product and Service Offerings
Table 7.261 Bavarian Nordic: Company Financial Strengths Analysis 2019 (US$Mn)
Table 7.262 Bavarian Nordic: Company Growth Share Analysis 2019 (US$Mn)
Table 7.263 Bavarian Nordic: Company Recent Developments till Dec,2020
Table 7.264 Bavarian Nordic: SWOT Analysis
Table 7.265 Strides Pharma Science Limited: Company Information
Table 7.266 Strides Pharma Science Limited: Company Product and Service Offerings
Table 7.267 Strides Pharma Science Limited: Company Financial Strengths Analysis 2019 (US$Mn)
Table 7.268 Strides Pharma Science Limited: Company Growth Share Analysis 2019 (US$Mn)
Table 7.269 Strides Pharma Science Limited: Company Recent Developments till Dec,2020
Table 7.270 Strides Pharma Science Limited: SWOT Analysis
Table 7.271 Consort Medical PLC: Company Information
Table 7.272 Consort Medical PLC: Company Product and Service Offerings
Table 7.273 Consort Medical PLC: Company Financial Strengths Analysis 2019 (US$Mn)
Table 7.274 Consort Medical PLC: Company Growth Share Analysis 2019 (US$Mn)
Table 7.275 Consort Medical PLC: Company Recent Developments till Dec,2020
Table 7.276 Consort Medical PLC: SWOT Analysis
Table 7.277 Catalent Pharma Solutions Inc: Company Information
Table 7.278 Catalent Pharma Solutions Inc: Company Product and Service Offerings
Table 7.279 Catalent Pharma Solutions Inc: Manufacturing Locations
Table 7.280 Catalent Pharma Solutions Inc: Company Financial Strengths Analysis 2019 (US$Mn)
Table 7.281 Catalent Pharma Solutions Inc: Company Growth Share Analysis 2019 (US$Mn)
Table 7.282 Catalent Pharma Solutions Inc: Company Recent Developments till Dec,2020
Table 7.283 Catalent Pharma Solutions Inc: SWOT Analysis
Table 7.284 Moderna Biotechnology: Company Information
Table 7.285 Moderna Biotechnology: Company Product and Service Offerings
Table 7.286 Moderna Biotechnology: Company Financial Strengths Analysis 2019 (US$Mn)
Table 7.287 Moderna Biotechnology: Company Growth Share Analysis 2019 (US$Mn)
Table 7.288 Moderna Biotechnology: Company Recent Developments till Dec,2020
Table 7.289 Moderna Biotechnology: SWOT Analysis
Table 7.290 Avid Bioservices, Inc: Company Information
Table 7.291 Avid Bioservices, Inc: Company Product and Service Offerings
Table 7.292 Avid Bioservices, Inc: Manufacturing Locations
Table 7.293 Avid Bioservices, Inc: Company Financial Strengths Analysis 2019 (US$Mn)
Table 7.294 Avid Bioservices, Inc: Company Growth Share Analysis 2019 (US$Mn)
Table 7.295 Avid Bioservices, Inc: Company Recent Developments till Dec,2020
Table 7.296 Avid Bioservices, Inc: SWOT Analysis
Table 7.297 Novavax Inc: Company Information
Table 7.298 Novavax Inc: Company Financial Strengths Analysis 2019 (US$Mn)
Table 7.299 Novavax Inc: Company Growth Share Analysis 2019 (US$Mn)
Table 7.300 Novavax Inc: Company Recent Developments till Dec,2020
Table 7.301 Novavax Inc: SWOT Analysis
Table 7.302 Inovio Pharmaceutical: Company Information
Table 7.303 Inovio Pharmaceutical: Company Product and Service Offerings
Table 7.304 Inovio Pharmaceutical: Manufacturing Locations
Table 7.305 Inovio Pharmaceutical: Company Financial Strengths Analysis 2019 (US$Mn)
Table 7.306 Inovio Pharmaceutical: Company Growth Share Analysis 2019 (US$Mn)
Table 7.307 Inovio Pharmaceutical: Company Recent Developments till Dec,2020
Table 7.308 Inovio Pharmaceutical: SWOT Analysis
Table 7.309 VBI Vaccines Biotechnology: Company Information
Table 7.310 VBI Vaccines Biotechnology: Company Product and Service Offerings
Table 7.311 VBI Vaccines Biotechnology: Company Financial Strengths Analysis 2019 (US$Mn)
Table 7.312 VBI Vaccines Biotechnology: Company Growth Share Analysis 2019 (US$Mn)
Table 7.313 VBI Vaccines Biotechnology: Company Recent Developments till Dec,2020
Table 7.314 VBI Vaccines Biotechnology: SWOT Analysis
List of Figure
Figure 3.1 Prominent Factors Affecting Growth of Pharmaceutical Contract Manufacturing Market
Figure 3.2 Market Drivers for Growth of Pharmaceutical Contract Manufacturing Market
Figure 3.3 Opportunities in the Global Pharmaceutical Contract Manufacturing Market
Figure 3.4 Growth Restrains in the Global Pharmaceutical Contract Manufacturing Market
Figure 3.5 SWOT Analysis of Pharmaceutical Contract Manufacturing Market
Figure 3.6 Porter’s Five Forces Analysis of Pharmaceutical Contract Manufacturing Market
Figure 5.1 Global Pharmaceutical Contract Manufacturing Market by Value Forecast 2021-2031 (US$ billion, AGR %)
Figure 5.2 Global Pharmaceutical Contract Manufacturing Market by Value Forecast 2021-2031 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 5.3 Global Pharmaceutical Contract Manufacturing Market by Value Forecast 2021-2031 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 5.4 Global Pharmaceutical Contract Manufacturing Market by Value Forecast 2021-2031 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 5.5 Global Pharmaceutical Contract Manufacturing Market by Value Forecast 2021-2031 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 5.6 Global Pharmaceutical Contract Manufacturing Market by Region Forecast 2021-2031 (US$ billion, AGR %)
Figure 5.7 Global Pharmaceutical Contract Manufacturing Market by Region Forecast 2021-2031 (US$ billion, AGR %) (V-Shaped Recovery)
Figure 5.8 Global Pharmaceutical Contract Manufacturing Market by Region Forecast 2021-2031 (US$ billion, AGR %) (W-Shaped Recovery)
Figure 5.9 Global Pharmaceutical Contract Manufacturing Market by Region Forecast 2021-2031 (US$ billion, AGR %) (U-Shaped Recovery)
Figure 5.10 Global Pharmaceutical Contract Manufacturing Market by Region Forecast 2021-2031 (US$ billion, AGR %) (L-Shaped Recovery)
Figure 7.1 Johnson & Johnson: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 7.2 Johnson & Johnson: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
Figure 7.3 : Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
Figure 7.4 F. Hoffmann-La Roche Ltd: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 7.5 F. Hoffmann-La Roche Ltd: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
Figure 7.6 F. Hoffmann-La Roche Ltd: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
Figure 7.7 Pfizer Pharmaceutical: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 7.8 Pfizer Pharmaceutical: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
Figure 7.9 Pfizer Pharmaceutical: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
Figure 7.10 Bayer Pharmaceutics: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 7.11 Bayer Pharmaceutics: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
Figure 7.12 Bayer Pharmaceutics: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
Figure 7.13 Novartis Pharmaceutical: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 7.14 Novartis Pharmaceutical: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
Figure 7.15 Novartis Pharmaceutical: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
Figure 7.16 Merck & Co. Inc: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 7.17 Merck & Co. Inc: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
Figure 7.18 Merck & Co. Inc: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
Figure 7.19 GlaxoSmithKline Pharmaceutical: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 7.20 GlaxoSmithKline Pharmaceutical: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
Figure 7.21 GlaxoSmithKline Pharmaceutical: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
Figure 7.22 Sanofi Pharmaceutical: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 7.23 Sanofi Pharmaceutical: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
Figure 7.24 Sanofi Pharmaceutical: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
Figure 7.25 AbbVie Inc: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 7.26 AbbVie Inc: Company Regional Revenue Market Share Analysis 2019 (US$Mn) 2019 (US$Mn)
Figure 7.27 AbbVie Inc: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
Figure 7.28 Abbott Laboratories: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 7.29 Abbott Laboratories: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
Figure 7.30 Abbott Laboratories: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
Figure 7.31 Thermo Fisher Scientific Inc: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 7.32 Thermo Fisher Scientific Inc: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
Figure 7.33 Thermo Fisher Scientific Inc: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
Figure 7.34 AstraZeneca Pharmaceutical: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 7.35 AstraZeneca Pharmaceutical: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
Figure 7.36 AstraZeneca Pharmaceutical: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
Figure 7.37 Eli Lily and Company: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 7.38 Eli Lily and Company: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
Figure 7.39 Eli Lily and Company: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
Figure 7.40 Gilead Science Inc: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 7.41 DuPont Chemical: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 7.42 Novo Nordisk Pharmaceutical: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 7.43 Novo Nordisk Pharmaceutical: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
Figure 7.44 Novo Nordisk Pharmaceutical: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
Figure 7.45 Merck KGaA: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 7.46 Merck KGaA: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
Figure 7.47 Merck KGaA: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
Figure 7.48 Siemens Healthineers Healthcare: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 7.49 Siemens Healthineers Healthcare: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
Figure 7.50 Siemens Healthineers Healthcare: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
Figure 7.51 Becton Dickinson Medical device: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 7.52 Becton Dickinson Medical device: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
Figure 7.53 Becton Dickinson Medical device: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
Figure 7.54 Teva Pharmaceutical: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 7.55 Evonik Industries: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 7.56 Evonik Industries: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
Figure 7.57 Evonik Industries: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
Figure 7.58 Stryker Corporation: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 7.59 Stryker Corporation: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
Figure 7.60 Stryker Corporation: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
Figure 7.61 Baxter Biopharma Solutions: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 7.62 Baxter Biopharma Solutions: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
Figure 7.63 : Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
Figure 7.64 Boston Scientific Manufacturing: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 7.65 Boston Scientific Manufacturing: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
Figure 7.66 Boston Scientific Manufacturing: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
Figure 7.67 Koninklijke DSM N.V: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 7.68 CSL Limited Biotechnology: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 7.69 CSL Limited Biotechnology: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
Figure 7.70 CSL Limited Biotechnology: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
Figure 7.71 Lonza Group AG: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 7.72 Lonza Group AG: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
Figure 7.73 Lonza Group AG: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
Figure 7.74 McKesson Corporation Medical: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 7.75 McKesson Corporation Medical: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
Figure 7.76 McKesson Corporation Medical: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
Figure 7.77 Edwards Lifesciences: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 7.78 Edwards Lifesciences: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
Figure 7.79 Edwards Lifesciences: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
Figure 7.80 Nipro Corporation: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 7.81 PPD Inc: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 7.82 Grifols Pharmaceutical: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 7.83 Biomerieux Biotechnology Company: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 7.84 Biomerieux Biotechnology Company: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
Figure 7.85 Biomerieux Biotechnology Company: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
Figure 7.86 Aurobindo Pharma Limited: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 7.87 Aurobindo Pharma Limited: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
Figure 7.88 Dr. Reddy's Laboratories: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 7.89 Dr. Reddy's Laboratories: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
Figure 7.90 Dr. Reddy's Laboratories: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
Figure 7.91 Wuxi AppTec: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 7.92 Huapont Life Sciences Co Ltd: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 7.93 Zhejiang Hisun Pharmaceutical: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 7.94 Alkermes Biotechnology: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 7.95 Emergent BioSolutions: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 7.96 Divi’s Laboratories: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 7.97 Divi’s Laboratories: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
Figure 7.98 Bavarian Nordic: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 7.99 Bavarian Nordic: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
Figure 7.100 Bavarian Nordic: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
Figure 7.101 Strides Pharma Science Limited: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 7.102 Strides Pharma Science Limited: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
Figure 7.103 Consort Medical PLC: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 7.104 Consort Medical PLC: Company Regional Revenue Market Share Analysis 2019 (US$Mn) 2019 (US$Mn)
Figure 7.105 Consort Medical PLC: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
Figure 7.106 Catalent Pharma Solutions Inc: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 7.107 Catalent Pharma Solutions Inc: Company Regional Revenue Market Share Analysis 2019 (US$Mn)
Figure 7.108 Catalent Pharma Solutions Inc: Company Revenue Breakdown by Business Segments Analysis 2019 (US$Mn)
Figure 7.109 Moderna Biotechnology: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 7.110 Avid Bioservices, Inc: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 7.111 Novavax Inc: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 7.112 Inovio Pharmaceutical: Company Revenue 2015-2019 (US$Mn, AGR %)
Figure 7.113 VBI Vaccines Biotechnology: Company Revenue 2015-2019 (US$Mn, AGR %)
Top 50 Companies Profiled in the Report
AbbVie Inc Company
Aenova Group Company
Ajinomoto Bio-Pharma Services Company
Alcami Corporation Company
Alkermes Biotechnology company
Almac Group Company
Aurobindo Pharma Ltd.
Avid Bioservices Inc.
Baxter Biopharma Solutions Company
Bayer AG Company
Biocon Limited Company
Biomay AG Company
Biophore India Pharmaceuticals Private Limited Company
Bora Pharmaceuticals Company
C.H. Boehringer Sohn AG & Ko. KG Company
Cambrex Corporation Company
Cardinal Health, Inc. Company
Catalent Pharma Solutions Inc.
Cepia Sanofi Company (Parental of Sanofi)
Charles River Laboratories International, Inc. Company
Consort Medical plc
Corden Pharma International Company
Daito Pharmaceutical Co., Ltd. Company
Delpharm SAS Company
Divi's Laboratories Ltd
DPT Laboratories, Ltd. (Mylan N.V.) Company
Dr. Reddy's Laboratories Company
Evonik Degussa Company
F. Hoffmann-La Roche Ltd
Famar S.A. Company
Fareva Pharmaceuticals Company
Fujifilm Diosynth Biotechnologies (Merck & co subsidiaries)
GlaxoSmithKline Pharmaceutical Company
Huapont Life Sciences Co Ltd Company
Koninklijke DSM N.V. (Royal DSM) Company
Lonza AG Company
Nipro Corporation
Pfizer Company
Recipharm AB Company
SAFC Biosciences (Merck KGaA Subsidiaries) Company
Samsung Biologics Company
Siegfried Holding Company
Strides Pharma Science Limited Company
Teva Pharmaceuticals Company
Therapure Biopharma, Inc. Company
Thermo Fisher Scientific Inc.
UPM Pharmaceuticals Company
Vetter Pharma Company
WuXi AppTec Company
Zhejiang Hisun Pharmaceutical Company
List of Companies Mentioned in the Report
AbbVie
Actavis
ADC Biotechnology
Aegerion Pharmaceuticals
Aenova Group
Aesica Pharma
Agensys
Agila Specialties
Ajinomoto Althea Inc
Alexion Pharmaceuticals
Almac Group
Althea Technologies
AMRI (Albany Molecular Research Inc)
API Corporation (APIC)
Aspen Pharmacare
Astellas
AstraZeneca
Banner Life Sciences
Banner Pharmacaps
Baring Private Equity Asia
Bausch & Lomb
Bayer Healthcare
Ben Venue Laboratories
Bend Research
Biogen Idec
BioIndustry Association (BIA)
Biotest
Blackstone Group
Boehringer Ingelheim
Boehringer Ingelheim BioXcellence
Bristol-Myers Squibb Company
Bushu Pharmaceuticals
Cambrex
Cambridge Major Laboratories
Catalent Pharma Solutions
Cedarburg Hauser
Cell Therapy Catapult
Celldex Therapeutics
Celltrion
Cenexi
Chemisch-Pharmazeutisches Laboratorium Ravensburg
Chemtrix
China FDA (CFDA)
Cipla
Cook Pharmica
CordenPharma
CTC Bio
Daito Pharmaceutical
Delpharm
Dishman Pharmaceuticals
DPx Fine Chemicals
DPx Holdings B.V.
Dr. Reddy’s Laboratories
DSP (DSM Sinochem Pharmaceuticals)
Eisai
Eli Lilly
Esteve Quimica
Euticals
Evonik Degussa
Famar
Fareva
FUJIFILM Diosynth Biotechnologies,
G-CON
Gallus Biopharmaceutical, LLC.
GEA Pharma-Systems
Genentech
GlaxoSmithKline (GSK)
Granules India
Haupt Pharma
Hexal
Hospira
Hospira One2One
ImmunoGen
Immunomedics
Indian Pharmaceutical Alliance
Innovent Biologics
IRIX Pharmaceuticals
Janssen
JK Pharmaceutical
Johnson & Johnson
Knowledge Transfer Network (KTN)
Lonza
Lupin
Marinopoulos Group
Matrix Laboratories
Medice
Medichem
Merck & Co.
Micron Technologies
Millennium
Mitsui & Co
Momenta Pharmaceuticals
Mylan
Neuland Laboratories
NICE Insight
NPS Pharmaceuticals
Nycomed
Orchid Chemicals & Pharmaceuticals
Oxford Biomedica
Patheon
Patheon Biologics
Pfizer
Pharmapak Technologies
Piramal Pharma Solutions
Progenics
Quintiles
Recepta Biopharma
Recipharm
Redwood Bioscience
Rentschler Biotechnologie
Roche
Royal DSM
SAFC
SafeBridge
Samsung Bioepis
Samsung BioLogics
Sandoz
Sanofi
Seattle Genetics
Shandong Xinhua
ShangPharma
Shire
Siegfried AG
Sigmar Italia
SMS Pharmaceuticals
Solvias AG
Speedel
Stada
Stem CentRx
Stevenage Bioscience Catalyst
Takeda
Temmler Group
Teva API
Thermo Fisher Scientific
UMN Pharma
UNIGEN
Valeant Pharmaceuticals
Valerion Therapeutics, LLC.
Vetter Pharma-Fertigung GmbH
Vivante GMP Solutions
West Pharmaceutical Services
WuXi PharmaTech
Zhangjiang Biotech & Pharmaceutical Base Company
Zhejiang Jiang Yuan Tang Biotechnology
List or Organizations Mentioned in the Report
Agência Nacional de Vigilância Sanitária (ANVISA)
Asociación Española de Fabricantes de Productos de Química Fina (AFAQUIM)
Associação Brasileira da Indústria Farmoquímica e de Insumos Farmacêuticos (ABIQUIFI)
Association of British Pharmaceutical Industry (ABPI)
Central Drugs Standard Control Organization (CDSCO)
Department of Health and Family Welfare
Development and Reform Commission (NDRC)
European Commission
European Medicines Agency (EMA)
Food and Drug Administration (US FDA)
Indian Drug Manufacturer’s Association (IDMA)
International Society of Pharmaceutical Engineering (IPSE)
Korea Food and Drug Administration (KFDA)
Korea Pharmaceutical Manufacturer’s Association (KPMA)
Medicines and Healthcare Products Regulatory Agency (MHRA)
Medicines Manufacturing Industry Partnership (MMIP)
Ministry of Health (MOH)
Ministry of Health, Labor and Welfare (MHLW)
Ministry of Industry and Information Technology (MIIT)
Pharmaceutical and Medical Devices Agency (PMDA)
World Health Organization (WHO)
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
